Current and historical gross, operating and net profit margin for Biolase (BIOL) over the last 10 years. The current net profit margin for Biolase as of March 31, 2018 is -40.31%.
|Biolase Annual Profit Margin Summary
|Biolase Quarterly Profit Margin Summary
||Medical & Dental Supplies
Biolaw Technology, Inc. is the world's leading dental laser company, is a medical technology company that develops, manufactures and markets lasers and related products focused on technologies that advance the practice of dentistry and medicine. The Company's products incorporate patented and patent pending technologies designed to provide clinically superior performance with less pain and faster recovery times. BIOLASE's principal products are dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications. Other products under development address ophthalmology and other medical and consumer markets.